|
Volumn 8, Issue 1, 2008, Pages 10-12
|
The Thyroid and Metabolism: The Action Continues
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
GC 1;
KB 2115;
LIOTHYRONINE;
THYROID HORMONE;
THYROID HORMONE RECEPTOR;
THYROTROPIN;
THYROXINE;
ADIPOGENESIS;
BONE DISEASE;
CARDIOTOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
EUTHYROID SICK SYNDROME;
GENE MUTATION;
HEART DISEASE;
HORMONAL REGULATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTHYROIDISM;
HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM;
HYPOTHYROIDISM;
MULTIPLE DRUG DOSE;
MUSCLE DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
RECEPTOR OCCUPANCY;
SIGNAL TRANSDUCTION;
SINGLE DRUG DOSE;
THYROID HORMONE METABOLISM;
THYROID HORMONE RESISTANCE;
TISSUE SPECIFICITY;
WHITE ADIPOSE TISSUE;
ANIMALS;
HUMANS;
METABOLISM;
RECEPTORS, THYROID HORMONE;
SIGNAL TRANSDUCTION;
SOCIETIES, SCIENTIFIC;
THYROID DISEASES;
THYROID GLAND;
THYROID HORMONES;
|
EID: 45549108071
PISSN: 15504131
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cmet.2008.06.008 Document Type: Conference Paper |
Times cited : (21)
|
References (12)
|